Initial Safety Results from a Phase II Study of Acalabrutinib Plus RICE Followed by Autologous Hematopoietic Cell Transplantation And/or Acalabrutinib Maintenance Therapy for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Blood(2020)
Key words
B-Cell Receptor Signaling
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined